Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Parallel Goups Study, Aimed to Evaluating Possible Benefits of the Treatment of New Generation Hypoglycaemic Drugs Compared to Sulphonylureas for the Tratment of Type 2 Diabetes Mellitus

NCT04272359 is registered in ClinicalTrials.gov with University of Milan as lead sponsor.

NCT NCT04272359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04272359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Parallel Goups Study, Aimed to Evaluating Possible Benefits of the Treatment of New Generation Hypoglycaemic Drugs Compared to Sulphonylureas for the Tratment of Type 2 Diabetes Mellitus
Lead sponsor
University of Milan
Phase
Observational
Overall status
Unknown status
Start date
May 6, 2019
Completion date
December 31, 2021
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

albuminuria, diet, healthy, renal function disorder, t2dm (type 2 diabetes mellitus)